More about

Emory University

News
June 15, 2020
2 min read
Save

Belantamab mafodotin: A ‘big step forward’ in relapsed, refractory multiple myeloma

Belantamab mafodotin: A ‘big step forward’ in relapsed, refractory multiple myeloma

Belantamab mafodotin produced sustained clinically meaningful responses in patients with relapsed or refractory multiple myeloma, according to findings from the DREAMM-2 study presented at ASCO.

News
June 12, 2020
5 min read
Save

Low-dose radiation after transoral resection effective in HPV-related oropharynx cancer

Low-dose radiation after transoral resection effective in HPV-related oropharynx cancer

Transoral resection followed by low-dose radiation appeared safe and effective for patients with p16-positive oropharynx cancer, according to results of a randomized phase 2 trial presented during the ASCO20 Virtual Scientific Program.

News
June 12, 2020
4 min read
Save

An ‘urgent need’: Steps to increase black participation in diabetes clinical trials

An ‘urgent need’: Steps to increase black participation in diabetes clinical trials

Data from clinical trials show that findings often do not apply to minority populations, and trialists must adopt cultural competency practices to recruit and retain black participants, according to a speaker.

News
June 04, 2020
4 min read
Save

Nivolumab plus ipilimumab confers sustained survival benefit in advanced NSCLC

Nivolumab plus ipilimumab confers sustained survival benefit in advanced NSCLC

Nivolumab plus ipilimumab continued to provide long-term OS benefits compared with chemotherapy as initial treatment for advanced non-small cell lung cancer, according to study results presented during the ASCO20 Virtual Scientific Program.

News
April 19, 2020
2 min read
Save

Physicians receive awards for service to patients near end of life

Physicians receive awards for service to patients near end of life

Five physicians received Hastings Center Cunniff-Dixon Physician Awards in recognition of their exemplary service to patients near the end of life.

News
April 14, 2020
2 min read
Save

Experts: HHS plan to optimize ventilators is ‘suboptimal’

Experts: HHS plan to optimize ventilators is ‘suboptimal’

The HHS assistant secretary for health and the U.S. surgeon general are asking health care providers to repurpose and share ventilators, cancel elective surgeries and transfer equipment and personnel to areas hardest hit by the COVID-19 pandemic.

News
February 20, 2020
11 min read
Save

Push to end HIV epidemic in US complicated by ‘brain drain’

Fewer medical trainees are entering the field of HIV, leaving a shortage in the workforce that is likely to get worse, experts said. The trend coincides with slowed progress in reducing new infections, and likely complicates a lofty new federal plan to end the U.S. epidemic in 10 years.

News
January 08, 2020
5 min read
Save

In-office testing, off-label therapy may be best approach for EKC

In-office testing, off-label therapy may be best approach for EKC

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

News
December 27, 2019
3 min read
Save

Anti-BCMA immunoconjugate appears effective for multiple myeloma

Anti-BCMA immunoconjugate appears effective for multiple myeloma

Belantamab mafodotin, an investigational anti-B-cell maturation antigen monoclonal antibody-drug conjugate, demonstrated clinically meaningful response rates among patients with heavily pretreated multiple myeloma, according to results of the randomized phase 2 DREAMM-2 trial published in Lancet Oncology.

News
December 27, 2019
4 min read
Save

Oral arginine therapy appears safe, effective for sickle cell disease pain management

Oral arginine therapy appears safe, effective for sickle cell disease pain management

ORLANDO — Oral supplementation with arginine resulted in faster resolution of pain associated with vaso-occlusive episodes among younger patients with sickle cell disease, according to the results of a randomized phase 2 trial presented at ASH Annual Meeting and Exposition.

View more